Company profile

Empatica Srl

Remote Patient Monitoring & Wearables

Company profile

About Empatica Srl

Empatica is a medical technology company specializing in wearable devices and digital biomarker platforms for remote patient monitoring and clinical research. Founded over a decade ago, the company has pioneered digital biomarker development in neurology, achieving the first FDA-cleared digital biomarker in the field. The Empatica Health Monitoring Platform combines award-winning medical-grade wearables (EmbracePlus and EmbraceMini) with sophisticated software and cloud infrastructure to collect clinical-quality physiological data from patients in real-world settings. The company's technology enables continuous monitoring of multiple physiological parameters including electrodermal activity (EDA), photoplethysmography (PPG), accelerometer, gyroscope, and temperature data. With over 300 digital measures available from a single wearable device, Empatica serves pharmaceutical companies, academic researchers, and healthcare providers across multiple therapeutic areas including epilepsy, Parkinson's disease, sleep disorders, and ADHD. Empatica holds 8 FDA clearances and CE MDR certification, with products deployed in over 160 countries and available in more than 40 languages. The company's technology has been referenced in over 12,000 research papers and is used by more than half of the top 20 pharmaceutical companies for clinical trials and digital endpoint development. The platform supports all phases of clinical trials with end-to-end remote monitoring capabilities, automated data collection, and real-time data transfer to secure cloud infrastructure. Empatica maintains ISO 13485 certification and operates from headquarters in Cambridge, Massachusetts, USA and Milano, Italy.

Company description Empatica Srl official website

Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Empatica Srl?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • ADHD
  • Cardiometabolic conditions
  • Epilepsy
  • Movement disorders
  • Obstructive sleep apnea (OSA)
  • Parkinson's disease
  • Sleep disorders

Who it serves

  • Academic researchers
  • Clinical research organizations (CROs)
  • Health systems
  • Healthcare providers
  • Pharmaceutical companies

Deployment & integration

Api Only · Cloud Saas · Embedded deployment with recorded integration context.

Recorded integration context: CRO platforms, eCOA systems.

Geographic context

Markets160+ countries globally · Australia · Canada · European Union · New Zealand · United Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

FDA clearance for EmbraceMini sleep monitoring (January 2026), CE MDR certification for Parkinson's Monitoring using PKG measures (January 2026), Partnership with DATALAND announced (2026), Launch of Parkinson's Monitoring solution combining PKG measures with Empatica wearables

Partnerships

Recorded partners

  • DATALAND (Omni-Sensory Museum)
  • European Union Horizon 2020 funded consortia
  • Over half of top 20 pharmaceutical companies
  • PKG (Parkinson's monitoring)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Care Portal

Secure online portal for managing studies, sites, and visualizing patient data

Software · Cloud SaaSCompany source

Cloud API for Clinical Trials

Direct API access to raw data and digital biomarkers from the Empatica Cloud

Api · Api OnlyCompany source

eCOA

Electronic Clinical Outcome Assessment integration for richer, integrated trial data

Software · Cloud SaaSCompany source

Embrace2

Peace of mind epilepsy monitoring (no longer available for purchase)

Device · EmbeddedCompany source

EmbraceMini

The world's smallest actigraphy wearable for clinical trials and clinical care

Device · EmbeddedCompany source

EmbracePlus

The world's most advanced and versatile medical wearable with 5 powerful sensors

Device · EmbeddedCompany source

Empatica Health Monitoring Platform

FDA-cleared full-stack health monitoring platform with medical-grade wearables and digital biomarkers

Platform · Cloud SaaSCompany source

EpiMonitor

Next-generation epilepsy monitoring available in US, UK, EU, AU, NZ and CA

Software · Cloud SaaSCompany source

Parkinson's Monitoring

Modern, patient-friendly continuous tracking of motor symptoms and therapy response

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

100,000+ devices deployed

Global deployment across patients and trial participants

300+ digital measures

Largest range of digital measures from a single wearable solution

12,000+ research papers

Academic publications using or referencing Empatica technology

160+ countries

Global availability in over 40 languages

ADHD Monitoring Consortium (EU Horizon 2020)

Monitoring adult ADHD and cardiometabolic conditions to develop ways to monitor symptoms and risks for optimized and personalized treatment approaches

Acquired new and unique real-world data using continuous health monitoring to contribute to optimized treatment approaches

DATALAND

Partnership with the world's first omni-sensory museum for health monitoring applications

Sleep Revolution Consortium (EU Horizon 2020)

Diagnosing and treating Obstructive Sleep Apnea (OSA) using machine learning approach with EmbracePlus to accurately diagnose OSA and provide optimal treatment

Brought together researchers and patients from across Europe under a single platform for OSA research

Takeda

Creating a digital biomarker for Fabry Disease diagnosis by exploring correlation between Electrodermal Activity (EDA) and sweat patterns using EmbracePlus

Successfully created a digital biomarker for Fabry Disease, a rare genetic disorder causing absent or reduced sweating

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Empatica Srl

Recent articles published on Empatica Srl's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Remote Patient Monitoring & Wearables

Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon